The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
A shedding soluble form of interleukin-17 receptor D exacerbates collagen-induced arthritis through facilitating TNF-α-dependent receptor clustering
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Overexpression of miR-223-3p could down-regulate IL-17RD expression and alleviate RA-induced injury 100, 101.”
From miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation (2021) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of Sef, a novel modulator of FGF signalling
Tsang, M., Friesel, R., Kudoh, T., & Dawid, I. B. (2002) · Nature Cell Biology · doi:10.1038/ncb749 · Cited by 304
Research works printed but not linked: 39
- Choy, E. H. & Panayi, G. S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med. 344, 907–916 (2001). · DOI · Paper page
- Feldmann, M. & Maini, R. N. Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat. Med. 9, 1245–1250 (2003). · DOI · Paper page
- McInnes, I. B. & Schett, G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7, 429–442 (2007). · DOI · Paper page
- McInnes, I. B., Buckley, C. D. & Isaacs, J. D. Cytokines in rheumatoid arthritis—shaping the immunological landscape. Nat. Rev. Rheumatol. 12, 63–68 (2016). · DOI · Paper page
- Probert, L. TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects. Neuroscience 302, 2–22 (2015). · DOI · Paper page
- Locksley, R. M., Killeen, N. & Lenardo, M. J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487–501 (2001). · DOI · Paper page
- Chan, F. K. et al. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288, 2351–2354 (2000). · DOI · Paper page
- Williams, R. O., Feldmann, M. & Maini, R. N. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl Acad. Sci. USA 89, 9784–9788 (1992). · DOI · Paper page
- Deng, G. M., Zheng, L., Chan, F. K. & Lenardo, M. Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors. Nat. Med. 11, 1066–1072 (2005). · DOI
- Su, Y. et al. Interleukin-17 receptor D constitutes an alternative receptor for interleukin-17A important in psoriasis-like skin inflammation. Sci. Immunol. 4, eaau9657 (2019). · DOI
- Rong, Z. et al. IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling. Cell Res. 19, 208–215 (2009). · DOI
- Mellett, M. et al. Orphan receptor IL-17RD tunes IL-17A signalling and is required for neutrophilia. Nat. Commun. 3, 1119 (2012). · DOI
- Fuchs, Y. et al. Sef is an inhibitor of proinflammatory cytokine signaling, acting by cytoplasmic sequestration of NF-kappaB. Dev. Cell. 23, 611–623 (2012). · DOI
- Mellett, M. et al. Orphan receptor IL-17RD regulates Toll-like receptor signalling via SEFIR/TIR interactions. Nat. Commun. 6, 6669 (2015). · DOI
- Yang, S. et al. Tumor necrosis factor receptor 2 (TNFR2).interleukin-17 receptor D (IL-17RD) heteromerization reveals a novel mechanism for NF-kappaB activation. J. Biol. Chem. 290, 861–871 (2015). · DOI
- Yang, S. et al. A novel multifunctional compound camellikaempferoside B decreases abeta production, interferes with abeta aggregation, and prohibits abeta-mediated neurotoxicity and neuroinflammation. ACS Chem. Neurosci. 7, 505–518 (2016). · DOI
- Jiang, C. et al. MicroRNA-26a negatively regulates toll-like receptor 3 expression of rat macrophages and ameliorates pristane induced arthritis in rats. Arthritis Res. Ther. 16, R9 (2014). · DOI
- Vingsbo, C. et al. Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am. J. Pathol. 149, 1675–1683 (1996).
- Delgado, Mario, Martinez, C., Leceta, J. & Gomariz, R. P. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat. Med. 7, 563–568 (2001). · DOI · Paper page
- Chyuan, I.-T., Tsai, H.-F., Liao, H.-J., Wu, C.-S. & Hsu, P.-N. An apoptosis-independent role of TRAIL in suppressing joint inflammation and inhibiting T-cell activation in inflammatory arthritis. Cell. Mol. Immunol. 14, 1–12 (2017). · DOI
- Zunke, F. & Rose-John, S. The shedding protease ADAM17: Physiology and pathophysiology. Biochim. Biophys. Acta Mol. Cell Res. 1864, 2059–2070 (2017). · DOI · Paper page
- Caescu, C. I., Jeschke, G. R. & Turk, B. E. Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10. Biochem. J. 424, 79–88 (2009). · DOI · Paper page
- Xiong, S. et al. hSef inhibits PC-12 cell differentiation by interfering with Ras-mitogen-activated protein kinase MAPK signaling. J. Biol. Chem. 278, 50273–50282 (2003). · DOI
- Trimble, R. B. & Tarentino, A. L. Identification of distinct endoglycosidase (endo) activities in Flavobacterium meningosepticum: endo F1, endo F2, and endo F3. Endo F1 and endo H hydrolyze only high mannose and hybrid glycans. J. Biol. Chem. 266, 1646–1651 (1991). · DOI · Paper page
- Pinckard, J. K., Sheehan, K. C. & Schreiber, R. D. Ligand-induced formation of p55 and p75 tumor necrosis factor receptor heterocomplexes on intact cells. J. Biol. Chem. 272, 10784–10789 (1997). · DOI
- Sidibe, A. et al. Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: evidence for tumor necrosis factor alpha-induced VE-cadherin cleavage. Arthritis Rheum. 64, 77–87 (2012). · DOI
- Zhang, Y. et al. LAIR-1 shedding from human fibroblast-like synoviocytes in rheumatoid arthritis following TNF-alpha stimulation. Clin. Exp. Immunol. 192, 193–205 (2018). · DOI
- Nielsen, M. A. et al. A disintegrin and metalloprotease-17 and galectin-9 are important regulators of local 4-1BB activity and disease outcome in rheumatoid arthritis. Rheumatology 55, 1871–1879 (2016). · DOI
- Liu, F. L., Wu, C. C. & Chang, D. M. TACE-dependent amphiregulin release is induced by IL-1beta and promotes cell invasion in fibroblast-like synoviocytes in rheumatoid arthritis. Rheumatology 53, 260–269 (2014). · doi:10.1093/rheumatology/ket350
- Gjelstrup, L. C. et al. Shedding of large functionally active CD11/CD18 Integrin complexes from leukocyte membranes during synovial inflammation distinguishes three types of arthritis through differential epitope exposure. J. Immunol. 185, 4154–4168 (2010). · DOI
- Xie, J. & Wang, H. Semaphorin 7A as a potential immune regulator and promising therapeutic target in rheumatoid arthritis. Arthritis Res. Ther. 19, 10 (2017). · doi:10.1186/s13075-016-1217-5
- Di Giovine, F. S., Nuki, G. & Duff, G. W. Tumour necrosis factor in synovial exudates. Ann. Rheum. Dis. 47, 768–772 (1988). · doi:10.1136/ard.47.9.768
- Ruspi, G. et al. TNFR2 increases the sensitivity of ligand-induced activation of the p38 MAPK and NF-kappaB pathways and signals TRAF2 protein degradation in macrophages. Cell Signal. 26, 683–690 (2014). · DOI
- Siegmund, D., Ehrenschwender, M. & Wajant, H. TNFR2 unlocks a RIPK1 kinase activity-dependent mode of proinflammatory TNFR1 signaling. Cell Death Dis. 9, 921 (2018). · DOI
- Scott, D. L., Wolfe, F. & Huizinga, T. W. Rheumatoid arthritis. Lancet 376, 1094–1108 (2010). · DOI · Paper page
- Hyrich, K. L. et al. Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study. Arthritis Rheum. 56, 13–20 (2007). · DOI · Paper page
- Hetland, M. L. et al. Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry. Arthritis Rheum. 62, 22–32 (2010). · DOI
- Gottenberg, J. E. et al. Non-TNF-targeted biologic vs a second anti-TNF drug to treat rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug: a randomized clinical trial. JAMA 316, 1172–1180 (2016). · DOI · Paper page
- Rossi, D., Modena, V., Sciascia, S. & Roccatello, D. Rheumatoid arthritis: biological therapy other than anti-TNF. Int. Immunopharmacol. 27, 185–188 (2015). · DOI
Cited by
miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation
Jiao, P., Wang, X.-P., Luoreng, Z.-M., Yang, J., Jia, L., Ma, Y., & Wei, D.-W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59876 · Cited by 151
Self-citation
Metadata
- Authors
- Liu, S., Fu, Y., Mei, K., Jiang, Y., Sun, X., Wang, Y., Ren, F., Jiang, C., Meng, L., Lu, S., Qin, Z., Dong, C., Wang, X., Chang, Z., & Yang, S.
- Venue
- Cellular & Molecular Immunology
- Published
- 2020-09-22
- Volume
- 18
- Issue
- 8
- Pages
- 1883-1895
- ISSN
- 1672-7681
- 2042-0226
- Cited by
- 13
- References
- 1
- Language
- en
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Funders
- National Natural Science Foundation of China (81830092, 81572729, 81872244)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A shedding soluble form of interleukin-17 receptor D exacerbates collagen-induced arthritis through facilitating TNF-α-dependent receptor clustering. https://app.cochat.ai/papers/10.1038/s41423-020-00548-w
- The paper
- Liu, S., Fu, Y., Mei, K., Jiang, Y., Sun, X., Wang, Y., Ren, F., Jiang, C., Meng, L., Lu, S., Qin, Z., Dong, C., Wang, X., Chang, Z., & Yang, S. (2021). A shedding soluble form of interleukin-17 receptor D exacerbates collagen-induced arthritis through facilitating TNF-α-dependent receptor clustering. Cellular & Molecular Immunology. https://doi.org/10.1038/s41423-020-00548-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.